Program

Meeting Agenda

Society for Birth Defects Research and Prevention 2023 (BDRP)
63rd Annual Meeting
Improving Pregnancy Outcomes through Collaborative Research

Download Printable Agenda PDF

Please note that The times listed are in EDT – Eastern Daylight Time (US).

Expand/Collapse

3:00 PM–6:00 PM


7:30 AM–5:00 PM


8:00 AM–8:30 AM


8:30 AM–12:00 Noon

Organized by the Education Committee,
Chairperson: Wafa A. Harrouk, Center for Drug Evaluation and Research, US FDA



8:30 AM–8:40 AM


8:40 AM–8:45 AM


8:45 AM–9:30 AM


9:30 AM–10:15 AM


10:15 AM–10:30 AM


10:30 AM–11:15 AM


11:15 AM–12:00 Noon


12:00 Noon–1:30 PM


1:30 PM–5:00 PM

Organized by the Education Committee
Chairperson: Wafa A. Harrouk, Center for Drug Evaluation and Research, US FDA



1:30 PM–1:35 PM


1:35 PM–2:25 PM


2:25 PM–3:15 PM


3:15 PM–3:30 PM


3:30 PM–4:15 PM


4:15 PM–5:00 PM


5:00 PM–7:00 PM


7:00 AM–6:00 PM


8:00 AM–8:15 AM


8:15 AM–9:00 AM


9:05 AM–12:05 PM





9:05 AM–9:10 AM


9:10 AM–9:30 AM
1


9:30 AM–9:50 AM
2


9:50 AM–10:10 AM
3


10:10 AM–10:30 AM
4


10:30 AM–10:45 AM


10:45 AM–11:05 AM
5


11:05 AM–11:25 AM
6


11:25 AM–11:45 PM
7


11:45 PM–12:05 PM
8

12:05 PM–1:30 PM


12:05 PM–1:30 PM


12:30 PM–1:30 PM


12:30 PM–1:30 PM


1:30 PM–2:00 PM


2:00 PM–2:30 PM


2:35 PM–3:35 PM


2:35 PM–2:55 PM
9


2:55 PM–3:15 PM
10


3:15 PM–3:35 PM
11


3:35 PM–3:50 PM


3:50 PM–5:20 PM



3:50 PM–4:10 PM
S1


4:10 PM–4:30 PM
S2


4:30 PM–4:50 PM
S3


4:50 PM–5:10 PM
S4


5:10 PM–5:20 PM


5:25 PM–5:55 PM


6:00 PM–7:30 PM


 

P1

Chambers CD, Jones KL, Johnson DL, Xu R, Luo Y. University of California San Diego, La Jolla, CA, United States. Paxlovid Prophylaxis or Treatment in Pregnancy: Data from the Organization of Teratology Information Specialists (OTIS) Pregnancy Registry

 

P2

Rudenb X, Singh A, Rass L, Chakravarty A, Awonuga AO, Ruden DM, Puscheck EE, Kidder B, Rappolee DA. Wayne State University, Detroit, MI, United States. Optimization of a Placental TSC High-Throughput Screen (HTS) that Reports Stress-Forced Stemness Override to Premature Imbalanced First Lineage Differentiation and Predicts Miscarriage

 

P3

Sant KE, Wilson PW, Yost J, Navarrete J, Cho CS, Schwartz AV. San Diego State University, San Diego, CA, United States. Developmental Toxicity of the Emerging Contaminants Tris(4-Chlorophenyl) Methane (TCPM) and Tris(4-Chlorophenyl) Methanol (TCPMOH) and Impacts on Pancreatic Organogenesis

 

P4

Harris SF1, Cunny HC2, Stinson K3, Shockley KR4. 1Social & Scientific Systems, a DLH Holdings Company, Durham, NC, United States, 2Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States, 3Southern Research, Birmingham, AL, United States, 4Division of Intramural Research, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States. Statistical Analysis of Fetal Defect Data: A Cautionary Tale

 

P5

Phanavanh B1, Moore J1, Davis K2, Li X3, Sung K3, Nakamura N1. 1National Center for Toxicological Research, Jefferson, AR, United States, 2Toxicologic Pathology Associates, Jefferson, AR, United States, 3Center for Biologics Evaluations and Research, Silver Spring, MD, United States. Determination of the Effects of Prenatal Remdesivir Exposure on Placenta Morphology, Placental IgG Transfer, and Fetal Growth in a Humanized Mouse Model

 

P6

Fish EW, Vashakidze D, Garcia JV, Benhabbour R, Martina M, Parnell SE. University of North Carolina, Chapel Hill, NC, United States. Interaction between Maternal Diet and the Effects of Prenatal Exposure to a Long-Acting Dolutegravir Formulation in C57BL/6J Mice

 

P7

Palmi ER1, Rose CE1, Archer NP2, Broussard CS1, Crider KS1, Green RF3, Olshan AF4, Reefhuis J1, Zarate YA5,6, Ailes EC1. 1National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, United States, 2Environmental Epidemiology and Disease Registries Section, Texas Department of State Health Services, Austin, TX, United States, 3Office of Genomics and Precision Public Health, Centers for Disease Control and Prevention, Atlanta, GA, United States, 4Department of Epidemiology, University of North Carolina, Chapel Hill, NC, United States, 5Section of Genetics and Metabolism, University of Arkansas for Medical Sciences, Little Rock, AR, United States, 6Division of Genetics and Metabolism, University of Kentucky, Lexington, KY, United States. Association between Parental Ages and Birth Defects

 

P8

Thai TN1, Maro JC2, Brown J1,3, Schmidt S4, Sonja A Rasmussen5, Winterstein AG1,3,6. 1Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States, 2Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, United States, 3Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville, FL, United States, 4Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, United States, 5Department of Genetic Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States, 6Department of Epidemiology, College of Medicine and College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States. In Utero Antiemetic Combination during the First Trimester and Adverse Circulatory Outcomes: A Signal Identification Analysis

 

P9

Khan NS1,2, Ait Belkacem N1,2, Sheehy O2, Patricia P2, Bérard A1,2. 1University of Montréal, Montréal, QC, Canada. 2CHU Sainte-Justine Research Centre, Montréal, QC, Canada. COVID-19 during Pregnancy: Prevalence, Predictors, and Impact on the Newborn

 

P10

Ailes EC, Broussard CS1, Crider KS1, Desrosiers TA2, Gilboa SM1, Howley MM3, Moore C1, Tepper NK1, Waller DK4, Jennita Reefhuis J1. 1National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, GA, United States, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, United States, 3New York State Department of Health, Albany, NY, United States, 4University of Texas Health Sciences Center at Houston, Houston, TX, United States. Associations between Antibiotics and Noncardiac Birth Defects, National Birth Defects Prevention Study and Birth Defects Study to Evaluate Pregnancy Exposures

 

P11

Leal LF, Sheehy O, BÉRARD A. CHU Sainte-Justine Research Centre, Montréal, QC, Canada. The AMerican PREGNANcy-Mother-Child Cohort (AM-PREGNANT): Description and Prevalence of Main Perinatal Outcomes and Medication Use

 

P12

Raskind-Hood CL1, Kancherla V1, Rodriguez FH2, Sullivan AM3, Lui G4, Botto L5, Feldkamp M5, Li J6, D'Ottavio A6, Farr S7, Glidewell J7, Book WM2,1. 1Emory University School of Public Health, Atlanta, GA, United States, 2Emory University School of Medicine, Atlanta, GA, United States, 3New York State Health Department, Albany, NY, United States, 4Divisions of Cardiovascular Medicine and Pediatric Cardiology, Stanford University School of Medicine, Palo Alto, CA, United States, 5Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, UT, United States, 6Duke University School of Medicine, Durham, NC, United States, 7National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, United States. Racial/Ethnic Disparities in Healthcare Utilization and Mortality among Individuals with Documented Congenital Heart Defects at Healthcare Encounters, Four US Surveillance Sites, 20112013

 

P13

Ephross S, Carneal-Frazer N, Brauneis J, Albano J. Syneos Health, Morrisville, NC, United States. Abortion-Related Trends before and after the Dobbs Decision within TriNetX Electronic Medical Record Data


P14

Anderson K, Callaway P. National Institute for Occupational Safety and Health, Morgantown, WV, United States. Characterizing Exposures from N-free Nail Polishes

 

P15

Lewis EM1, Hoberman AM1, Guenther C2, Bussi S3, Coppo A3, Jones P4, Hirani E4, Fretellier N5. 1Charles River Laboratories, Inc., Horsham, PA, United States, 2Bayer AG, Berlin, Germany, 3Bracco Imaging Spa, Milano, Italy, 4GE HealthCare, Chalfont St Giles, United Kingdom, 5Guerbet, Roissy, France. Juvenile Toxicity Studies Following Repeated Dose Administrations of Various Gadolinium (Gd) Based Contrast Agents (GBCAs) to Evaluate Potential Long-Term Effects and Presence of Gd in the Brain of Male and Female Mice

 

P16

Palmer JA, Donley ELR. Stemina Biomarker Discovery, Inc., Madison, WI, United States. Qualification of the devTOX quickPredict Assay for Regulatory Use Under the ICH S5(R3) Guidelines

 

P17

Lavu A1, Peymani P1, Alessi Severini S1, Ruth C2, Falk J1, Aboulatta L1, Haidar L1, Akinola S1, Farooq F1, Kowalec K1, Derksen S3, Leong C1, Ng M4, Kaul P5, Delaney J1, Eltonsy S1. 1College of Pharmacy, University of Manitoba, Winnipeg, MB, Canada, 2Max Rady School of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada, 3Manitoba Center for Health Policy (MCHP), Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, 4Section of Neurology, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada, 5Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada. Gabapentin Use during Pregnancy and Adverse Neonatal Birth Outcomes: A Population-Based Cohort Study

 

P18

Ewig C1, Muschett M1, Smolinski N1, Thai T1, Rasmussen SA2, Winterstein A1. 1University of Florida, Gainesville, FL, United States, 2Johns Hopkins School of Medicine, Baltimore, MD, United States. Secular Trends and Determinants of Hepatitis C Virus Testing during Pregnancy

 

P19

Yang S, Yan J, Guo L, Pan L, McPherson S. WuXi AppTec (Suzhou) Co., Ltd., Suzhou, Jiangsu, China. Investigation of Fertility and Early Embryonic Development to Implantation of Cyclophosphamide in Mice

 

P20

Singh A1,2, Ruden XL2,3, Marben T4, Tang W5, Feng H5, Awonuga AO2, Ruden DM1,2,6, Puscheck EE2,3,7, Rappolee DA2,3,7. 1Center of Molecular Medicine and Genomics, Wayne State University, Detroit, MI, United States, 2C. S. Mott Center for Human Growth and Development, Wayne State University, Detroit, MI, United States, 3Reproductive Stress Inc, Grosse Pointe Farms, MI, United States, 4University of Detroit Mercy, Detroit, MI, United States, 5Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, United States, 6Institute of Environmental Health Sciences, Wayne State University, Detroit, MI, United States, 7Invia Fertility, Detroit, United States. A Single Cell Transcriptomic Fingerprint of Premature, Imbalanced Differentiation of Embryonic Stem Cells (ESC)

 

LB1

Beaudry F, Maghezzi SM, Authier S, Sparapani S, Movasseghi R, Buenafe AC. Charles River Laboratories, Laval, QC, Canada. Direct Cisterna Magna Injection Method for Juvenile Rats Study

 

7:30 PM–9:30 PM


7:00 AM–4:30 PM


7:00 AM–8:00 AM


7:00 AM–8:00 AM


8:00 AM–9:00 AM


9:05 AM–12:00 Noon


9:05 AM–9:15 AM


9:15 AM–9:45 AM
S5


9:45 AM–10:15 AM
S6


10:15 AM–10:30 AM


10:30 AM–11:00 AM
S7


11:00 AM–11:30 AM
S8


11:30 AM–12:00 Noon


9:05 AM–12:00 Noon




9:05 AM–9:15 AM


9:15 AM–9:30 AM
12


9:30 AM–9:45 AM
13


9:45 AM–10:00 AM
14


10:00 AM–10:15 AM
15


10:15 AM–10:30 AM


10:30 AM–10:45 AM
16


10:45 AM–11:00 AM
17


11:00 AM–11:15 AM
18


11:15 AM–11:30 AM
19


11:30 AM–11:45 AM
20


11:45 AM–12:00 Noon
21



12:00 Noon–2:00 PM


12:05 PM–1:45 PM
12:05 PM–12:10 PM


12:10 PM–12:20 PM


12:20 PM–12:30 PM


12:30 PM–12:55 PM


12:55 PM–1:05 PM


1:05 PM–1:15 PM


1:15 PM–1:45 PM


2:00 PM–2:30 PM


2:35 PM–5:30 PM


2:35 PM–2:40 PM


2:40 PM–3:20 PM
S9


3:20 PM–4:00 PM
S10


4:00 PM–4:15 PM


4:15 PM–4:45 PM
S11


4:45 PM–5:30 PM


5:30 PM–7:00 PM


 

P21

Pique C, Marsden E, Quesada P, Blondel A. Charles River Laboratories, Lyon, France. A Regulatory Preliminary Embryo-Fetal Developmental Toxicity Study in the Minipig with Shortened Design

 

P22

Wiegand J1, Avila-Barnard S1, Nemarugommula C1, Lyons D1, Zhang S2, Stapleton HM2, Volz DC1. 1University of California, Riverside, Riverside, CA, United States, 2Duke University, Durham, NC, United States. Triphenyl Phosphate-Induced Pericardial Edema in Zebrafish Embryos is Dependent on the Ionic Strength of Exposure Media

 

P23

Mohan H1, Nguyen J1, Sanghvi T1, Tejada O1, Laurette EY1, Guzman-Lenis M1, Greene N2, Copp A2, Serghides L1,3. 1Toronto General Hospital Research Institute, Princess Margaret Cancer Research Tower (PMCRT), University Health Network, Toronto, ON, Canada, 2Developmental Biology and Cancer Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom, 3Department of Immunology and Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada. A Comparative Study of Pregnancy Outcomes in Mice Treated with Integrase Strand Transfer Inhibitors (INSTI)

 

P24

Gray RO, Lovely CB. University of Louisville, Louisville, KY, United States. Characterizing the Ethanol Sensitivity of the Planar Cell Polarity Pathway in Endoderm Morphogenesis and Jaw Development

 

P25

Malin AJ1, Samy S2, Hu H3, Martinez-Mier EA4, Eckel SP3, Farzan SF3, Howe CG5, Funk W6, Habre R3, Bastain TM3, Breton CV3. 1University of Florida, Gainesville, FL, United States, 2Trace Organics Analytical Center, University of Washington, Seattle, WA, United States, 3Keck School of Medicine of USC, Los Angeles, CA, United States, 4School of Dentistry, Indiana University, Indianapolis, IN, United States, 5Geisel School of Medicine at Dartmouth College, Lebanon, NH, United States, 6Feinberg School of Medicine, Northwestern University, Chicago, IL, United States. Urinary Aluminum Levels in Relation to Urinary Fluoride and Metal Co-exposures among Pregnant Women in Los Angeles, California

 

P26

Laham M1,2, Sheehy O2, Mainbourg S2,1, Bérard A1,2. 1Montréal University-Faculty of Pharmacy, Montréal, QC, Canada, 2Research Centre-CHU Sainte-Justine, Montréal, QC, Canada. Impact of Levothyroxine Use during Pregnancy in Hypothyroidism, on Perinatal Outcomes and Child Neurocognitive Development

 

P27

Dave AA. Mercer University School of Medicine, Macon, GA, United States. Vaginitis? It must Yeast!—Addressing the Negative Impact of Self-Diagnosis of Vulvovaginitis

 

P28

Gorgui J1, Sheehy O2, Trasler J3, Bérard A1. 1University of Montréal, Montréal, QC, Canada, 2Research Centre-CHU Sainte-Justine, Montréal, QC, Canada. 3RI-McGill University Health Centre, Montréal, QC, Canada. Trends in Medically Assisted Reproduction Utilization and Perinatal Outcomes in Quebec between 2005 and 2015: The Impact of the Universal Access ProgramAn Interrupted Time Series Analysis

 

P29

Ait Belkacem N1,2, Gorgui J1,2, Lippé S1,2, Bérard A1,2. 1University of Montréal, Montréal, QC, Canada,  2Research Center CHU Ste-Justine, Montréal, QC, Canada. Maternal Mental Health during the COVID-19 Pandemic and Its Impact on Child Cognitive Development

 

P30

Hall-Lande J1, Pettingell S1, Bershadsky J1, Larson S1, Hallas L1, Riley C2, Liu T2, Reefhuis J2. 1University of Minnesota, Minneapolis, MN, United States, 2Centers for Disease Control and Prevention, Atlanta, GA, United States. Estimating Prevalence of Spina Bifida in the US Using Administrative Databases

 

P31

Smolinski NE, Sarayani A, Thai T, Jugl S, Ewig C, Winterstein AG. University of Florida, Gainesville, FL, United States. Prenatal Exposure to Valproic Acid in the United States

 

P32

Dorsey A1, Downing KF2, Danielson M2, Kancherla V1, Oster ME2,3, Farr S2. 1Department of Epidemiology, Emory University, Rollins School of Public Health, Atlanta, GA, United States, 2Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Atlanta, GA, United States, 3Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA, United States. Mental, Behavioral, and Developmental Disorders (MBDDs) Among US Children with and without Heart Conditions, 20162021

 

P33

Carter T. Marshfield Clinic, Marshfield, WI, United States. Identification of Genomic Regulatory Elements in Human Palatal Mesenchyme Cells

 

P34

DeSesso JM, Williams AL. Exponent, Alexandria, VA, United States. Evaluation of the Developmental and Reproductive Toxicity Potential of Titanium Dioxide

 

P35

Avila-Barnard SG, Weigand JL, Nemarugommula C, Volz DC. University of California, Riverside, CA, United States. Tris (1,3-dichloro-2-propyl)phosphate Disrupts Cellular Metabolism within Human Embryonic Kidney (HEK293) Cells

 

P36

Lavu A1, Peymani P1, Alessi-Severini S1, Ruth C2, Falk J1, Haidar L1, Aboulatta L1, Akinola S1, Farooq F1, Kowalec K1, Leong C1, Derksen S3, Ng M4, Delaney J1, Kaul P5, Eltonsy S1. 1College of Pharmacy, University of Manitoba, Winnipeg, MB, Canada, 2Max Rady School of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada, 3Manitoba Center for Health Policy (MCHP), Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, 4Section of Neurology, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada, 5Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. Antiseizure Medication Use in Pregnancy and Adverse Neonatal Birth Outcomes: A Population-Based Cohort Study

 

P37

Aboulatta L1, Momo K2, Sasaki T2, Tan Q1, Eltonsy S1. 1University of Manitoba, Winnipeg, MB, Canada, 2Showa University, Tokyo, Japan. Stillbirth Rates before and during the COVID-19 Pandemic in Manitoba (Canada) and Japan

 

P38

Lowdermilk MM1,2, Evanovich DM1,2, Wang JT2,3, Sadhwani A3,4, Sansevero T5, Zendejas B3,5, Bajic D2,3. 1Tufts University School of Medicine, Boston, MA, United States, 2Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s Hospital, Boston, MA, United States, 3Harvard Medical School, Boston, MA, United States, 4Department of Psychiatry, Boston Children’s Hospital, Boston, MA, United States, 5Department of Surgery, Esophageal and Airway Treatment Center, Boston Children’s Hospital, Boston, MA, United States. Growing Up after Critical Care: Early Neurodevelopmental Outcomes in Esophageal Atresia

 

P39

Jones KL, Chambers CD. University of California San Diego, La Jolla, CA, United States. Considering Fetal Alcohol Spectrum Disorders as a Mitigating Factor in Death Row Cases in the US

 

P40

Williams AL, DeSesso JM. Exponent, Alexandria, VA, United States. An Extended One-Generation Reproductive Toxicity Study (EOGRT) of Food-Grade Titanium Dioxide

 

LB2

TUKEMAN GL1, WEI H1, FINNELL RH1,2,3, CABRERA RM1. 1Baylor College of Medicine, Department of Molecular and Cellular Biology, Houston, TX, United States, 2Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, TX, United States, 3Baylor College of Medicine, Department of Medicine, Houston, TX, United States. Dolutegravir Induced Neural Tube Defects in Mice are Folate Responsive

 

LB3

Fisher SC1, Howley MM1, Romitti PA2, Tracy M3, Jabs EW4,5, Browne ML1,3, For the National Birth Defects Prevention Study. 1Birth Defects Registry, New York State Department of Health, Albany, NY, United States. 2Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, United States, 3Department of Epidemiology and Biostatistics, School of Public Health, University at Albany, Rensselaer, NY, United States, 4Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States, 5Department of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD, United States. Maternal Periconceptional Alcohol Consumption and Omphalocele Among Offspring in the National Birth Defects Prevention Study (1997–2011)

 


5:30 PM–6:15 PM

6:15 PM–7:00 PM


7:00 AM–3:30 PM


7:00 AM–8:00 AM


7:00 AM–8:00 AM


7:00 AM–8:00 AM


7:00 AM–8:00 AM


8:00 AM–9:00 AM


9:05 AM–12:00 Noon


9:05 AM–9:40 AM
S12


9:40 AM–10:15 AM
S13


10:15 AM–10:30 AM


10:30 AM–11:05 AM
S14


11:05 AM–11:45 AM
S15


11:45 AM–12:00 Noon


9:05 AM–12:00 Noon


9:05 AM–9:10 AM


9:10 AM–9:40 AM
S16


9:40 AM–10:15 AM
S17


10:15 AM–10:30 AM


10:30 AM–11:05 AM
S18


11:05 AM–11:40 AM
S19


11:40 AM–12:00 Noon


12:00 Noon–1:45 PM


12:00 Noon–12:10 PM


12:10 PM–12:50 PM


12:50 PM–1:30 PM


1:30 PM–1:45 PM


12:00 Noon–2:00 PM


2:00 PM–5:00 PM


2:00 PM–2:25 PM
S20


2:25 PM–2:50 PM
S21


2:50 PM–3:15 PM
S22


3:15 PM–3:30 PM


3:30 PM–3:55 PM
S23


3:55 PM–4:20 PM
S24


4:20 PM–4:45 PM
S25


4:45 PM–5:00 PM


5:05 PM–6:30 PM


5:05 PM–5:10 PM


5:10 PM–5:30 PM


5:30 PM–6:15 PM


6:00 PM–6:30 PM


6:30 PM–8:00 PM


 

P41

Yaye AB1, Lemma TB2. 1Dire Dawa University, Dire Dawa, Ethiopia, 2Jimma University, Jimma, Ethiopia. Effect of Picture-Based Health Education and Counselling on Knowledge and Adherence to Preconception Iron-Folic Acid Supplementation among Women Planning to Be Pregnant in Eastern Ethiopia: A Randomized Controlled Trial

 

P42

Shafique S, Bile C, Winn L. Queen's University, Kingston, ON, Canada. Investigating the Effect of In Utero Benzene Exposure on mRNA and Protein Expression of Xrcc4, Xrcc5, Xrcc6, Rad51, and BRCA2 Genes in Murine Placenta

 

P43

Davis D1, Hrubec TC1,2, Kula J1, Kirkpatrick Z2. 1Edward Via College of Osteopathic Medicine, Blacksburg, VA, United States, 2Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA, United States. Morphological Differences in Mouse Embryos Following Quaternary Ammonium Compound Exposure

 

P44

Ghaffari R, Biven M, Albert A, Dong J. Corteva Agriscience, Newark, DE, United States. Characterization of Maternal Liver Enzyme Induction Effects on Thyroid-Related Endpoints in Offspring

 

P45

Fitzpatrick HT1, Wolf CJ2. 1ORISE, Oak Ridge, TN, United States, 2Environmental Protection Agency, ORD, CPHEA, Research Triangle Park, NC, United States. Antineoplastic and Antiepileptic Agents Inhibit Fusion in 3D Organotypic Human Palate Fusion Model

 

P46

Cen R1, Ying J1, Nembhard W1, Goudie A1, El-hassan N2. 1University of Arkansas for Medical Sciences College of Public Health, Little Rock, AR, United States, 2University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, AR, United States. Hospital Readmission within Five Years after Surgical Repair among Infants Born with Esophageal Atresia and/or Tracheoesophageal Fistula in Arkansas

 

P47

Bérard A1,2, Sheehy O2, Kaul P3, Eltonsy S4, Walker M5, Hawken S6, Bernatsky S7, Pugliese M6, Barrett O8, Savu A3, Dragan R4. 1University of Montréal, Montréal, QC, Canada, 2Research Centre-CHU Ste-Justine, Montréal, QC, Canada, 3University of Alberta, Edmonton, AB, Canada. 4University of Manitoba, Winnipeg, MB, Canada, 5The Ottawa Hospital, Ottawa, ON, Canada, 6The Ottawa Hospital Research Institute, Ottawa, ON, Canada, 7McGill University, Montréal, QC, Canada. 8Alberta Health Services, Edmonton, Alberta, Canada. COVID-19 Infection and Medicines in Pregnancy in Canada

 

P48

Maibourg S1, Sheehy O2, Vinet E3, Bérard A2,1. 1Université de Montréal, Montréal, QC, Canada, 2Centre de Recherche CHU Sainte Justine, Montréal, QC, Canada, 3Mc Gill University, Montréal, QC, Canada. Prevalence and Use of Medications for Autoimmune Diseases during Pregnancy

 

P49

Gorgui J1,2, Tchuente V2, Pagès N2,3, Fareh T2,3, Elgbeili G4, King S4, Bérard A1,2. 1University of Montréal, Montréal, QC, Canada, 2Research Centre-CHU Sainte-Justine, Montréal, QC, Canada. 3Université Claude Bernard-Lyon 1, Lyon, France, 4McGill University, Montréal, QC, Canada. The Impact of Prenatal Maternal Mental Health during the COVID-19 Pandemic on Birth Outcomes: A Study within CONCEPTION Cohort

 

P50

Wiesel A, Ma X, DiDomenico J, Wohler F, Roberts MH, Bakhireva LN. Substance Use Research and Education Center, University of New Mexico, Albuquerque, NM, United States. Dose-Response Effect of Prenatal Alcohol Exposure on Perinatal Outcomes

 

P51

Forestieri NE1, Olshan AF2, Oster ME3, Ailes EC4, Fundora MP4, Fisher SC5, Shumate C6, Romitti PA7, Liberman RF8, Nembhard WN9, Carmichael SL10, Desrosiers TA2. 1Birth Defects Monitoring Program, State Center for Health Statistics, Division of Public Health, North Carolina Department of Health and Human Services, Raleigh, NC, United States, 2Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States, 3Division of Pediatric Cardiology, Children’s Healthcare of Atlanta; and School of Medicine, Emory University, Atlanta, GA, United States, 4Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, United States, 5Birth Defects Research Section, New York State Department of Health, Albany, NY, United States, 6Birth Defects Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, TX, United States, 7Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, United States, 8Massachussets Center for Birth Defects Research and Prevention, Massachusetts Department of Public Health, Boston, MA, United States, 9Department of Epidemiology, College of Public Health; and Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States, 10Departments of Pediatrics and Obstetrics & Gynecology, Stanford University School of Medicine, Stanford, CA, United States. Survival of Children with Critical Congenital Heart Defects in the National Birth Defects Prevention Study

 

P52

Zhu Y1,2, Hernandez-Diaz S3, Anand P2, Bykov K2,1, Sarpatwari A1,2, Mahesri M2, DiCesare E2, Vine S2, Mogun H2, Huybrechts K1,2. 1Harvard Medical School, Boston, MA, United States, 2Brigham and Women’s Hospital, Boston, MA, United States, 3Harvard T.H. Chan School of Public Health, Boston, MA, United States. Assessment of the Effectiveness of Risk Evaluation and Mitigation Strategy for the Prevention of Fetal Exposure to Phentermine-Topiramate Using Two Large Nationwide Cohorts

 

P53

Potineni H, Happ HH, Carvill GL. Northwestern University Feinberg School of Medicine, Chicago, IL, United States. Using Cell-Free DNA to Detect Brain-Specific Variants in Epilepsy

 

P54

Stanislaus D1, Romach B2, Ziejewski M1. 1GlaxoSmithKline, Collegeville, PA, United States, 2ViiV Healthcare, Raleigh, NC, United States. Cabotegravir: Absence of Reproductive and Developmental Toxicity in Animal Studies

 

P55

Vannappagari V1,2, Albano JD3, Thorne C4, Ragone L1, Scheuerle AE5, Cook T3, Zhang C3, Rasi V4, de Ruiter A6, Giaquinto C7. 1ViiV Healthcare, Durham, NC, United States, 2Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, United States, 3Syneos Health, Wilmington, NC, United States, 4University College London Great Ormond Street Institute of Child Health, London, United Kingdom, 5University of Texas Southwestern Medical Center, Dallas, TX, United States, 6ViiV Healthcare, London, United Kingdom, 7University of Padova, Padova, Italy. Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Cabotegravir (CAB): Data from the Antiretroviral Pregnancy Registry (APR) and European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC)

 

P56

Yuan F, Liu J, Chen S-y. Department of Pharmacology and Toxicology, University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, United States. Ethanol-Induced Dysregulation of Enhancers and Aberrant Expression of Their Cognate Genes Contribute to Craniofacial Defects in Zebrafish Embryos

 

P57

Ireland D, Miller J. CDH International, Wake Forest, NC, United States. Congenital Diaphragmatic Hernia: Patient Parents as Partners

 

P58

Sheehy O1, Eltonsy S2, Hawken S3,4, Walker M5, Kaul P6, Winquist B7, Barrett O8, Savu A6, Dragan R9, Pugliese M4, Bernatsky S10, Gorgui J1,11, BÉRARD A1,11,12. 1Research Centre, CHU Sainte-Justine, Montréal, QC, Canada, 2University of Manitoba, College of Pharmacy, Winnipeg, MB, Canada, 3University of Ottawa, Clinical Epidemiology, Ottawa, ON, Canada, 4ICES uOttawa, Ottawa, ON, Canada, 5University of Ottawa, Faculty of Medicine, Ottawa, ON, Canada, 6University of Alberta, Faculty of Medicine and Dentistry, Edmonton, AB, Canada. 7Saskatchewan Health Authority, Saskatoon, SK, Canada, 8Alberta Health Services, AHS Data and Analytics, Calgary, AB, Canada, 9University of Manitoba, Manitoba Centre for Health Policy, Winnipeg, MB, Canada, 10McGill University, Faculty of Medicine, Montréal, QC, Canada, 11University of Montréal, Faculty of Pharmacy, Montréal, QC, Canada. 12University of Claude Bernard, Faculty of Medicine, Lyon, France. Health Canada Advisory Impact on the Prevalence and Trends of Oral Codeine Use in the Pediatric Canadian Population: A Comparative Study across Provinces

 

P59

Rayhon SL1, Mulatu S2, Thompson KE1, Turner KJ1. 1Janssen, Spring House, PA, United States, 2Texas A&M University, College Station, TX, United States. A Retrospective Analysis of Fertility Assessments for Monoclonal Antibodies in Sexually Mature Nonhuman Primates

 

LB4

Hartvelt S, Lam E, Zhang G, Philippo C, Hendriks G, Jamalpoor A. Toxys B.V., Oegstgeest, The Netherlands. Application of ReproTracker in Assessing Developmental Toxicity According to ICH S5 (R3) Guideline

 

LB5

Guo Y1, Li Q1, Costanza J2, Rozowsky J3, Botek C2, Brown M1, Higgins D1, Zhu Y1, Farrow B1, Heath A1, Resnick A1, Ferretti V2, Kids First Data Resource Center4. 1Center for Data-Driven Discovery in Biomedicine at the Children’s Hospital of Philadelphia, Philadelphia, PA, United States, 2Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada, 3Velsera, Boston, MA, United States. 4kidsfirstdrc.org. Variant WorkBench Facilitates Discoveries in Genomics Research of Birth Defects and Rare Pediatric Disorders

 

LB6

Serradimigni R, Rojas A, Bryan M, Sharma S, Baltazar M, Dasgupta S. Clemson University, Clemson, SC, United States. Flame Retardant Tetrabromobisphenol A (TBBPA) Disrupts Embryogenesis during Zebrafish Zygotic Genome Activation

 

LB7

Anderson KR, Velaquez-Kronen R, Shockey T, Stueckle T, McKernan L. National Institute for Occupational Safety and Health, Morgantown, WV, United States. Expanding Partnerships to Prevent Reproductive Hazards in the Workplace: The NIOSH Chronic Disease Prevention Program

 

LB8

Molina-Martínez B1, del Pozo A1, Alzualde A1, Frías AM1, Muriana A1, Schiavone V2, Miguel Sanz C2, Di Donato V2, Truong L3, Tanguay R3, Ellis L4, Kluver N5, Hsieh JH6, Ryan K6, Cindy Woodland7, Sachana M8, Hessel E9. 1Biobide (BBD BioPhenix S.L.U), San Sebastián, Gipuzkoa, Spain, 2ZeClinics SL, Barcelona, Spain, 3Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, United States, 4National Research Council of Canada, Halifax, NS, Canada, 5Department of Bioanalytical Ecotoxicology, Helmholtz Centre for Environmental Research GmbH–UFZ, Leipzig, Germany, 6Division of the Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States, 7New Substances Assessment and Control Bureau, Health Canada, Ottawa, Canada, 8Organization for Economic Co-operation and Development, Paris, France, 9Consortium Coordinator, Centre for Health Protection, National Institute for Public Health and the Environment, Utrecht, The Netherlands. Interlaboratory Study for Harmonization and Validation of the Zebrafish Light-Dark Transition Test for Economic Co-operation and Development Developmental Neurotoxicity In Vitro Testing Battery

 

LB9

Kancherla V1,2, Rhoads A2, Conway KM2, Suhl J2, Langlois PH3, Hoyt AT4, Shaw GM5, Evans SP6,7, Moore CA7, Luben TJ8, Michalski AM9, Feldkamp ML10, Romitti PA2, National Birth Defects Prevention Study. 1Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, United States, 2Department of Epidemiology, College of Public Health, The University of Iowa, Iowa City, IA, United States, 3Department of Epidemiology, Human Genetics, and Environmental Science, University of Texas School of Public Health, Austin, TX, United States, 4Department of Health and Human Performance, University of Houston, Houston, TX, United States, 5Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States, 6Eagle Global Scientific LLC, San Antonio, TX, United States, 7US Centers for Disease Control and Prevention, Atlanta, GA, United States, 8Center for Public Health and Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park, NC, United States, 9New York State Department of Health, Bureau of Environmental and Occupational Epidemiology, Albany, NY, United States, 10Division of Medical Genetics, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, United States. Maternal Periconceptional Exposure to Drinking Water Disinfection By-Products and Neural Tube Defects in Offspring

 

LB10

Politis MD1,2, Shumate C3, Canfield MA3, Agopian AJ4, Bolin EH5, Zarate YA6, Maity S1, Morris S7, Malik S8, Insaf T9,10, Nembhard WN1,11, National Birth Defects Prevention Study. 1Arkansas Center for Birth Defects Research and Prevention, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, United States, 2Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States, 3Texas Birth Defects Epidemiology and Surveillance Branch, Austin, TX, United States, 4Department of Epidemiology, Human Genetics and Environmental Sciences, UT Health School of Public Health, Houston, TX, United States, 5Department of Pediatrics, Section of Pediatric Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR, United States, 6Department of Pediatrics, Section of Genetics and Metabolism, University of Arkansas for Medical Sciences, Little Rock, AR, United States, 7Baylor College of Medicine, Houston, TX, United States, 8Pediatric Cardiology, Department of Pediatrics, UT Southwestern Children's Medical Center, Dallas, TX, United States, 9Bureau of Environmental and Occupational Epidemiology, New York State Department of Health, Albany, NY, United States, 10Department of Epidemiology and Biostatistics, School of Public Health, University at Albany, State University of New York, Rensselaer, NY, United States, 11Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, United States. Maternal Racial/Ethnic Differences in Complexity of Congenital Heart Defects

 

LB11

Kim CK1, Chiang A1, Lowen S1, McDonald VA1, Luo X2, Hrubec TC1,2. 1 Edward Via College of Osteopathic Medicine, Blacksburg, VA, United States, 2VA-MD College of Veterinary Medicine Virginia Tech, Blacksburg, VA, United States. The Effect of Disinfectant Exposure on Multigenerational Changes in the Microbiome and Its Influence on the Development of Immune Function

 

LB12

Betancourt D1, Shumate C 1, Le M 1 Page R2, Morris T2, Ferdinand A2 Chaudhuri N2, Choudhury M2, Ayres S2, Sinha S 2. 1Birth Defects Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, TX, United States, 2Texas A&M University, College Station, TX, United States. Identifying Social Determinants of Health Associated with Survival Among Infants Born with Diaphragmatic Hernia, Transposition of the Great Arteries, and Tetralogy of Fallot in Texas, 2011–2019

 

LB13

LE M1, HOYT A2, CANFIELD M3, SHUMATE C1. 1Birth Defects Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, TX, United States, 2Department of Health and Human Performance, University of Houston, Houston, TX, United States, 3School of Public Health, The University of Texas Health Science Center, Austin, TX, United States. Association of Anotia/Microtia, Total Anomalous Pulmonary Venous Connection (TAPVC), and Biliary Atresia among Non-Hispanic Asian/Pacific Islanders in Texas, 1999–2019

 



6:30 AM–7:30 AM


7:30 AM–2:30 PM


8:00 AM–9:00 AM


9:05 AM–12:00 Noon


9:05 AM–9:40 AM
S26


9:40 AM–10:15 AM
S27


10:15 AM–10:45 AM


10:45 AM–11:10 AM
S28


11:10 AM–11:30 AM
S29


11:30 AM–11:50 AM
S30


11:50 AM–12:00 Noon


10:15 AM–10:45 AM


12:00 Noon–1:00 PM


12:00 Noon–1:00 PM


12:00 Noon–1:00 PM


12:00 Noon–1:00 PM


1:05 PM–4:00 PM


1:05 PM–1:40 PM
S31


1:40 PM–2:15 PM
S32


2:15 PM–2:30 PM


2:30 PM–3:05 PM
S33


3:05 PM–3:40 PM
S34


3:40 PM–3:55 PM


4:15 PM–5:30 PM


5:45 PM–6:45 PM


7:00 PM–9:00 PM


Society for Birth Defects Research and Prevention © Copyright 2023